Integrative Gastroenterology - an Observational Trial (InteGast)

Universität Duisburg-Essen

Status: Unknown

Conditions: Irritable Bowel Syndrome; Crohns Disease; Ulcerative Colitis

Treatments: Other: Integrative Therapy

Study type: Observational

Funder types: Other

Identifiers

NCT02476643

15-6183-BO InteGast

Details and patient eligibility

About

This study aims to test, if a two-week integrative therapy in an internal medicine ward will improve symptoms, disability and quality of life in patients with inflammatory bowel disease or irritable bowel syndrome.a It shall further be tested, if those changes are associated with attitudes and experiences towards complementary and alternative medicine, anxiety, depression and stress perception as well as body awareness and responsiveness.

Full description

see above

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years or older
• diagnosed with Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD)
• written informed consent

Exclusion criteria

• participation in other clinical studies

Trial design

200 participants in 1 patient group

Integrative Therapy

Description:

This group receives and integrative therapy at the Department of Internal and Integrative Medicine, i.e. a combination of conventional diagnostic and therapeutic interventions with specific naturopathic, and complementary medicine approaches, and physical therapy. Patients are admitted to the hospital ward for 14 days.

Treatment:

Other: Integrative Therapy